Skip to content

Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study

Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study With Long Term Data Collection for the Accolade® II Hip Stem

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01420237
Enrollment
367
Registered
2011-08-19
Start date
2011-06-30
Completion date
2023-11-09
Last updated
2025-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip

Keywords

Noninflammatory joint disease of the hip.

Brief summary

The purpose of this study is to evaluate the success rate of cementless primary hip replacement with the Restoration® ADM X3® Acetabular System as compared to other primary hip systems in the literature, through absence of femoral head dislocation at 10 years postoperative.

Detailed description

This study is a prospective, open-label, post-market, non-randomized, multi-center, clinical evaluation of the Restoration® ADM X3® Acetabular System for primary total hip arthroplasty (THA) with a cementless application in a consecutive series of patients who meet the eligibility criteria. The total enrollment goal for the study is 350 cases, all of which will receive the Restoration® ADM X3® Acetabular System. A minimum of 100 cases (within the study population) will receive the Accolade® II Hip Stem. The remaining cases will receive any other compatible Stryker femoral component. Data in the literature from other primary hip systems and similar dual mobility cups will be used as historical references.

Interventions

DEVICERestoration ADM X3 Device

Restoration ADM X3 Device in total hip replacement.

Sponsors

Stryker Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patient has signed an IRB/EC approved, study specific Informed Patient Consent Form. * Patient is a male or non-pregnant female, skeletally mature and age 18-75 years at time of study device implantation. * Patient has a diagnosis of Non-Inflammatory Degenerative Joint Disease (NIDJD). * Patient is a candidate for a primary cementless acetabular replacement. * Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion criteria

* Patient has a Body Mass Index (BMI) ≥ 40. * Patient has an active or suspected latent infection in or about the affected hip joint at time of study device implantation. * Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device. * Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's disease) leading to progressive bone deterioration. * Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days). * Patient requires revision surgery of a previously implanted total hip replacement or hip fusion to the affected joint. * Patient has a known sensitivity to device materials. * Patient is a prisoner.

Design outcomes

Primary

MeasureTime frameDescription
Success Rate10 years postoperativeDefined as absence of postoperative femoral head dislocation.

Secondary

MeasureTime frameDescription
All Cause Revision and Removal Rates of the Restoration ADM X3 Acetabular System10 yearsRevision or removal of any study component.
Patient Satisfaction and Pain: Follow-up Questionnaire6-10 yearsThis questionnaire will be used to obtain the following information: * Satisfaction with the hip replacement * Presence of any pain in the study hip * Surgeries performed on the study hip * Any dislocations in the study hip
Radiographic Stability Rates6 week,1, 2, 3, 4, 5 yearsCases that present with migration of greater than 5 mm in any direction or at least 2 mm radiolucency in all zones will be considered radiographic failures. All cases were assessed for any migration at the 6 week, 1,2,3,4,5 year time points.
Complication Rates for Psoas Impingement and Associated Groin Pain10 yearsReported occurrence of any participant/hip experiencing groin pain or psoas impingement.
Harris Hip Score (HHS) Score Improvement From Preoperative Scorepre-op, 6 week, 1,2,3,4,5 years. 7 and 10 years were optional.The Harris Hip Score (HHS) assesses pain, function, joint deformity and range of motion. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent 80-89 = good 70-79 = fair 0-69 = poor
Lower Extremity Activity Scale (LEAS) Improvement From Preoperative Scorepreop, 6 week, 1,2,3,4,5 yearsThe LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.
EQ-5D Index Score Improvement From Preoperative Scorepreop, 6 week, 1,2,3,4,5 yearsThe EQ-5D is a subject-completed questionnaire designed to assess subject health state values. The EQ-5D consists of 2 areas; the EQ visual analogue scale (EQ VAS) and EQ-5D descriptive system. The EQ VAS collects health state values using a 20 cm visual analogue scale with the endpoints labeled best imaginable health state at the top and worst imaginable health state at the bottom, having numeric values of 100 to 0 respectively. The EQ-5D Time Trade-off (TTO) descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/comfort and anxiety/depression. Each dimension has three levels: no problems, some problems and extreme problems. The index values on a scale between -1 (low) and 1 (high) are showing the average health status according to the 5 dimensions: A low score shows worse health, and a high score shows better health.
Percentage of Cases Which Did Not Have Any Component Revised10 yearsThe number of hips that did not undergo a removal/revision of any of the hip components.
Short Form-12 (SF-12) Improvement From Preoperative Scorepreop, 6 week, 1,2,3,4,5 yearsThe SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

Countries

Canada, Germany, United States

Participant flow

Recruitment details

There were 390 hips in 367 participants that were enrolled in the study. (23 bilateral cases).

Pre-assignment details

Of the 390 hips/367 participants enrolled there were 36 hips/34 participants censored due to not having the study device, surgery canceled or an inclusion exclusion violation so 354 hips/333 participants are followed who did receive the study device and met protocol criteria. Those applicable data are reflected in this record.

Participants by arm

ArmCount
Restoration ADM X3 Device
Restoration ADM X3 Device in total hip replacement. Restoration ADM X3 Device: Restoration ADM X3 Device in total hip replacement.
333
Total333

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event10
Overall StudyCensored because of Inclusion Exclusion Violation11
Overall StudyCensored because study device not implanted21
Overall StudyCensored because surgery not performed2
Overall StudyDeath13
Overall StudyInvestigative Site Termination43
Overall StudyLost to Follow-up32
Overall StudySponsor terminated study early127
Overall StudyWithdrawal by Subject41

Baseline characteristics

CharacteristicRestoration ADM X3 Device
Age, Continuous
Mean age
60.99 years
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
13 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
315 Participants
Sex: Female, Male
Female
164 Participants
Sex: Female, Male
Male
169 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 35413 / 333
other
Total, other adverse events
56 / 3540 / 333
serious
Total, serious adverse events
15 / 35466 / 333

Outcome results

Primary

Success Rate

Defined as absence of postoperative femoral head dislocation.

Time frame: 10 years postoperative

Population: Participants/hips with available data up to 10 years or at the time of early study termination.

ArmMeasureValue (NUMBER)
Restoration ADM X3 DeviceSuccess Rate354 hips
Secondary

All Cause Revision and Removal Rates of the Restoration ADM X3 Acetabular System

Revision or removal of any study component.

Time frame: 10 years

Population: Includes all participants who received the study device and were not censored from analysis.

ArmMeasureValue (NUMBER)
Restoration ADM X3 DeviceAll Cause Revision and Removal Rates of the Restoration ADM X3 Acetabular System12 hips
Secondary

Complication Rates for Psoas Impingement and Associated Groin Pain

Reported occurrence of any participant/hip experiencing groin pain or psoas impingement.

Time frame: 10 years

Population: Participants/hips that reported an event of groin pain or psoas impingement up until early study termination.

ArmMeasureValue (NUMBER)
Restoration ADM X3 DeviceComplication Rates for Psoas Impingement and Associated Groin Pain2 hips
Secondary

EQ-5D Index Score Improvement From Preoperative Score

The EQ-5D is a subject-completed questionnaire designed to assess subject health state values. The EQ-5D consists of 2 areas; the EQ visual analogue scale (EQ VAS) and EQ-5D descriptive system. The EQ VAS collects health state values using a 20 cm visual analogue scale with the endpoints labeled best imaginable health state at the top and worst imaginable health state at the bottom, having numeric values of 100 to 0 respectively. The EQ-5D Time Trade-off (TTO) descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/comfort and anxiety/depression. Each dimension has three levels: no problems, some problems and extreme problems. The index values on a scale between -1 (low) and 1 (high) are showing the average health status according to the 5 dimensions: A low score shows worse health, and a high score shows better health.

Time frame: preop, 6 week, 1,2,3,4,5 years

Population: Participants/hips with available data. In addition to the outcome measure time frame detailed above, data is presented at 7 and 10 years, but these visits were optional.

ArmMeasureGroupValue (MEAN)Dispersion
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D Pre-op67.22 score on a scaleStandard Deviation 19.16
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D 6 weeks78.58 score on a scaleStandard Deviation 15.53
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D 1-year82.9 score on a scaleStandard Deviation 13.76
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D 2-years83.89 score on a scaleStandard Deviation 13.14
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D 3-years84.14 score on a scaleStandard Deviation 12.29
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D 4-years83.18 score on a scaleStandard Deviation 12.54
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D 5-years81.26 score on a scaleStandard Deviation 14.63
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D 7-years80.5 score on a scaleStandard Deviation 16.21
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D 10-years81.58 score on a scaleStandard Deviation 21.09
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreE-5D TTO Pre-op0.63 score on a scaleStandard Deviation 0.19
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D TTO 6 weeks0.81 score on a scaleStandard Deviation 0.15
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D TTO 1-year0.89 score on a scaleStandard Deviation 0.13
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D TTO 2-years0.90 score on a scaleStandard Deviation 0.13
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D TTO 3-years0.91 score on a scaleStandard Deviation 0.13
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D TTO 4-years0.9 score on a scaleStandard Deviation 0.13
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D TTO 5-years0.89 score on a scaleStandard Deviation 0.15
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D TTO 7-years0.9 score on a scaleStandard Deviation 0.13
Restoration ADM X3 DeviceEQ-5D Index Score Improvement From Preoperative ScoreEQ-5D TTO 10-years0.92 score on a scaleStandard Deviation 0.17
Secondary

Harris Hip Score (HHS) Score Improvement From Preoperative Score

The Harris Hip Score (HHS) assesses pain, function, joint deformity and range of motion. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent 80-89 = good 70-79 = fair 0-69 = poor

Time frame: pre-op, 6 week, 1,2,3,4,5 years. 7 and 10 years were optional.

Population: Participants/hips with available data. In addition to the outcome measure time frame detailed above, data is presented at 7 and 10 years, but these visits were optional.

ArmMeasureGroupValue (MEAN)Dispersion
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative ScorePreoperative54.47 score on a scaleStandard Deviation 12.85
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative Score6 weeks79.56 score on a scaleStandard Deviation 14.03
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative Score1 year92.32 score on a scaleStandard Deviation 10.44
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative Score2 years92.99 score on a scaleStandard Deviation 10.35
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative Score3 years94.80 score on a scaleStandard Deviation 9
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative Score4 years94.22 score on a scaleStandard Deviation 9.06
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative Score5 years95.66 score on a scaleStandard Deviation 6.69
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative Score7 years93.77 score on a scaleStandard Deviation 9.22
Restoration ADM X3 DeviceHarris Hip Score (HHS) Score Improvement From Preoperative Score10 years95.43 score on a scaleStandard Deviation 7.67
Secondary

Lower Extremity Activity Scale (LEAS) Improvement From Preoperative Score

The LEAS is completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.

Time frame: preop, 6 week, 1,2,3,4,5 years

Population: Participants/hips with available data. In addition to the outcome measure time frame detailed above, data is presented at 7 and 10 years, but these visits were optional.

ArmMeasureGroupValue (MEAN)Dispersion
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative ScorePre-op9.2 score on a scaleStandard Deviation 3.06
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative Score6 weeks8.94 score on a scaleStandard Deviation 2.59
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative Score1-year11.49 score on a scaleStandard Deviation 2.94
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative Score2-years11.79 score on a scaleStandard Deviation 3.09
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative Score3-years11.82 score on a scaleStandard Deviation 2.96
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative Score4-years11.66 score on a scaleStandard Deviation 2.99
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative Score5-years11.62 score on a scaleStandard Deviation 2.99
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative Score7-years11.3 score on a scaleStandard Deviation 3.17
Restoration ADM X3 DeviceLower Extremity Activity Scale (LEAS) Improvement From Preoperative Score10-years10.84 score on a scaleStandard Deviation 3.21
Secondary

Patient Satisfaction and Pain: Follow-up Questionnaire

This questionnaire will be used to obtain the following information: * Satisfaction with the hip replacement * Presence of any pain in the study hip * Surgeries performed on the study hip * Any dislocations in the study hip

Time frame: 6-10 years

Population: Participants/hips with available data at the 6,7,8.9.10 years postoperative.

ArmMeasureGroupValue (COUNT_OF_UNITS)
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 6 years - Yes25 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 6 years - No172 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 6 years - Yes191 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 6 years - No4 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 6 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 6 years - No197 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 6 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 6 years - No197 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 7 years - Yes22 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 7 years - No141 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 7 years - Yes162 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 7 years - No1 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 7 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 7 years - No163 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 7 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 7 years - No163 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 8 years - Yes12 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 8 years - No117 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 8 years - Yes128 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 8 years - No1 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 8 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 8 years - No129 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 8 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 8 years - No129 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 9 years - Yes8 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 9 years - No73 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 9 years - Yes79 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 9 years - No1 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 9 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 9 years - No80 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 9 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 9 years - No80 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 10 years - Yes8 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnairePresence of any pain in the study hip at 10 years - No62 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 10 years - Yes69 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSatisfaction with the hip replacement at 10 years - No1 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 10 years - Yes1 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireSurgeries performed on the study hip at 10 years - No69 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 10 years - Yes0 hips
Restoration ADM X3 DevicePatient Satisfaction and Pain: Follow-up QuestionnaireAny dislocations in the study hip at 10 years - No70 hips
Secondary

Percentage of Cases Which Did Not Have Any Component Revised

The number of hips that did not undergo a removal/revision of any of the hip components.

Time frame: 10 years

Population: Participants/hips with available data at 10 years or at the time of early study termination. There were 12 hip revisions of the 354 hips in the study, leaving 342 hip cases without a revision of any components.

ArmMeasureValue (NUMBER)
Restoration ADM X3 DevicePercentage of Cases Which Did Not Have Any Component Revised342 hips
Secondary

Radiographic Stability Rates

Cases that present with migration of greater than 5 mm in any direction or at least 2 mm radiolucency in all zones will be considered radiographic failures. All cases were assessed for any migration at the 6 week, 1,2,3,4,5 year time points.

Time frame: 6 week,1, 2, 3, 4, 5 years

Population: Participants/hips with available radiographic data submitted at the outcome measure time frames.

ArmMeasureValue (NUMBER)
Restoration ADM X3 DeviceRadiographic Stability Rates0 hips
Secondary

Short Form-12 (SF-12) Improvement From Preoperative Score

The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

Time frame: preop, 6 week, 1,2,3,4,5 years

Population: Participants/hips with available data. In addition to the outcome measure time frame detailed above, data is presented at 7 and 10 years, but these visits were optional.

ArmMeasureGroupValue (MEAN)Dispersion
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative ScorePre-op Physical Component32.62 score on a scaleStandard Deviation 8.94
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score6 weeks Physical Component40.02 score on a scaleStandard Deviation 8.49
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score1-year Physical Component48.43 score on a scaleStandard Deviation 9.6
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score2-years Physical Component49.44 score on a scaleStandard Deviation 8.63
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score3-years Physical Component49.69 score on a scaleStandard Deviation 8.79
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score4-years Physical Component48.93 score on a scaleStandard Deviation 9.31
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score5-years Physical Component48.49 score on a scaleStandard Deviation 9.73
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score7-years Physical Component48.45 score on a scaleStandard Deviation 9.39
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score10-years Physical Component49.26 score on a scaleStandard Deviation 8.86
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative ScorePre-op Mental Component52.42 score on a scaleStandard Deviation 10.99
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score6 weeks Mental Component55.18 score on a scaleStandard Deviation 9.33
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score1-year Mental Component55.2 score on a scaleStandard Deviation 7.61
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score2-years Mental Component54.88 score on a scaleStandard Deviation 7.8
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score3-years Mental Component54.92 score on a scaleStandard Deviation 7.69
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score4-years Mental Component55.85 score on a scaleStandard Deviation 6.95
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score5-years Mental Component55.29 score on a scaleStandard Deviation 7.81
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score7-years Mental Component55.53 score on a scaleStandard Deviation 7.94
Restoration ADM X3 DeviceShort Form-12 (SF-12) Improvement From Preoperative Score10-years Mental Component55.73 score on a scaleStandard Deviation 8.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026